| 摘要 |
<p>Pharmaceutical compositions with anti-tumour activity with a base of α-bisabolol are provided: on cell lines in culture, a significant apoptotic activity of α-bisabolol has in fact been shown, which is therefore suitable, possibly associated with one or more pharmaceutically compatible excipients, for the preparation of pharmaceutical compositions for the treatment of tumours and, specifically, of leukaemia and of cerebral tumours such as glioblastoma.</p> |
